Saliva Clinical Trial
Official title:
Quality Improvement of Saliva by Chewing Tapioca Pearls in Bubble Tea Drinks
Verified date | December 2020 |
Source | Gadjah Mada University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Bubble tea drinks contain tea and tapioca pearls. Chewing tapioca pearls in bubble tea drinks may increase salivary components. Because of its proteins, inorganic components, and enzymes, saliva plays an important role in the body's defense against bacteria and viruses. This study aims to analyze the effect of chewing the tapioca pearls in bubble tea drinks on salivary C-reactive protein (CRP) and calcium (Ca) levels.
Status | Completed |
Enrollment | 15 |
Est. completion date | October 17, 2020 |
Est. primary completion date | October 17, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 25 Years |
Eligibility | Inclusion Criteria: - good Oral Hygiene Index-Simplified (OHI-S) score Exclusion Criteria: - taking medication - a history of dry mouth - smoking - systemic disease |
Country | Name | City | State |
---|---|---|---|
Indonesia | Faculty of Dentistry, Universitas Gadjah Mada | Yogyakarta |
Lead Sponsor | Collaborator |
---|---|
Gadjah Mada University |
Indonesia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Salivary C-reactive protein (CRP) level | Salivary CRP level was measured on the first day before chewing tapioca peals in the bubble tea drinks and drink tea. Salivary CRP level was measured on the third day after drink bubble tea and tea without tapioca pearls | 3 days | |
Secondary | Calcium (Ca) level | Ca level was measured on the first day before chewing tapioca peals in the bubble tea drinks and drink tea. Ca level was measured on the third day after drink bubble tea and tea without tapioca pearls | 3 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02554604 -
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
|
||
Completed |
NCT06437262 -
Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva
|
Phase 1 | |
Recruiting |
NCT06047132 -
PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED SUBJECTS
|
||
Completed |
NCT05635929 -
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.
|
N/A | |
Not yet recruiting |
NCT06276335 -
Influence of Timing of Implant Placement on Early Healing Molecular Events
|
N/A | |
Recruiting |
NCT06037603 -
Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)
|
N/A | |
Recruiting |
NCT05791149 -
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
|
N/A | |
Completed |
NCT05325983 -
Using Saliva Stimulation to Immediately Improve Heart Failure Inpatient's Thirst Sensation
|
N/A | |
Recruiting |
NCT06439095 -
Interleukin-2 (IL-2), Interleukin-5 (IL-5) and Interleukin-17 (IL-17) Levels of Patients With Stainless Steel Crowns
|
||
Completed |
NCT03612414 -
Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients
|
N/A | |
Recruiting |
NCT06354205 -
Comparison of Salivary Procalcitonin (PCT) Levels and Serum PCT Levels
|
N/A | |
Completed |
NCT04721457 -
The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load
|
Phase 4 | |
Completed |
NCT02149758 -
EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).
|
Phase 4 | |
Completed |
NCT05437874 -
Carbonated Beverage Consumption in pH and Bacterial Proliferation
|
Phase 1 | |
Completed |
NCT05793099 -
Effect of 5% Aqueous Propolis in Salivary and Dental Plaque pH in Children
|
N/A | |
Recruiting |
NCT05890469 -
Effect of Implant Surface Material and Topography on Bone Regeneration.
|
N/A | |
Completed |
NCT04352959 -
COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses
|
N/A |